These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Chemoimmunotherapy: an emerging strategy for the treatment of malignant mesothelioma. McCoy MJ; Nowak AK; Lake RA Tissue Antigens; 2009 Jul; 74(1):1-10. PubMed ID: 19422663 [TBL] [Abstract][Full Text] [Related]
12. Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors. Yan TD; Boyer M; Tin MM; Wong D; Kennedy C; McLean J; Bannon PG; McCaughan BC J Thorac Cardiovasc Surg; 2009 Sep; 138(3):619-24. PubMed ID: 19698846 [TBL] [Abstract][Full Text] [Related]
13. Cytoreductive surgery (cs) and hyperthermic intraperitoneal chemotherapy (hipec) in treatment of peritoneal surface malignances: report of a phase II clinical study. Asero S; Caruso M; Vallone N; Luciani AG; Lombardo V; Terranova G; Ettore G; Giannone G In Vivo; 2009; 23(4):645-7. PubMed ID: 19567402 [TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy as an innovative treatment for malignant pleural mesothelioma. Friedberg JS Semin Thorac Cardiovasc Surg; 2009; 21(2):177-87. PubMed ID: 19822291 [TBL] [Abstract][Full Text] [Related]
15. Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication. Wolf AS; Daniel J; Sugarbaker DJ Semin Thorac Cardiovasc Surg; 2009; 21(2):132-48. PubMed ID: 19822285 [TBL] [Abstract][Full Text] [Related]
20. The role of surgery in the management of malignant pleural mesothelioma. Foroulis CN; Zarogoulidis K; Papakonstantinou C J BUON; 2009; 14(2):173-81. PubMed ID: 19650163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]